Citation only
via Europe PMC
Frailty assessment in naturally aged mouse models: classification, limitations, and future directions.
GeroScience · 2026
Deregulated nutrient-sensing
Mitochondrial dysfunction
Cellular senescence
Chronic inflammation
Human
Mouse
Review
Abstract
Naturally aged mice provide an important platform for studying frailty because functional decline emerges during biological aging rather than through acute injury or artificial manipulation. This review critically examines major frailty assessment tools used in aged mice, including the mouse frailty index, mouse frailty phenotype, physical function score/vitality score, mouse social frailty index, and mouse cognitive frailty index. We compare their conceptual foundations, scoring procedures, dimensional coverage, reproducibility, mortality associations, intervention responsiveness, and translational correspondence with clinical models such as the Fried phenotype and deficit accumulation frailty index. We also discuss how biological mechanisms linked to the telomere(definition) attrition, cellular senescence(definition))." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">hallmarks of aging(definition), including inflammaging(definition), immunosenescence, mitochondrial dysfunction(definition), cellular senescence, altered nutrient sensing, and impaired stress resilience, may contribute to frailty development. Current instruments capture complementary aspects of frailty but differ in their dependence on subjective observation, cohort-specific thresholds, testing conditions, and validation across sex, strain, laboratory, and outcome. Digital phenotyping, longitudinal trajectories, secondary prognostic models, and measures of latent vulnerability may extend current approaches, but these strategies remain exploratory. Alternative weighting systems and the proposed distinction between pre-frailty and subclinical frailty require prospective validation before they can be considered standardized methods. Clear separation of established instruments from conceptual future directions will improve methodological rigor and translational relevance.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1007/s11357-026-02500-8
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
F, J., S, L., & L., Y. (2026). Frailty assessment in naturally aged mouse models: classification, limitations, and future directions. <em>GeroScience</em>. https://doi.org/10.1007/s11357-026-02500-8
Vancouver
F J, S L, L. Y. Frailty assessment in naturally aged mouse models: classification, limitations, and future directions. GeroScience. 2026. doi:10.1007/s11357-026-02500-8.
BibTeX
@article{ji2026Frailt,
title = {Frailty assessment in naturally aged mouse models: classification, limitations, and future directions.},
author = {Ji F and Li S and Yang L.},
journal = {GeroScience},
year = {2026},
doi = {10.1007/s11357-026-02500-8},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Heart Vessels and Transplantation 2026
Open access · CC-BY
Frailty assessment and management using the frailty index: A narrative review
Meir Medical Center 2018
Open access · US-GOV
Frailty Assesment in the Congestive Heart Failure Clinic
MedComm – Future Medicine 2025
Open access · CC-BY
Mitochondrial Dysfunction in Aging: Future Therapies and Precision Medicine Approaches
International Journal of Veterinary Sciences and Animal Husbandry 2026
Open access · OA
Senotherapeutics: emerging pharmacological strategies for targeting cellular senescence
Duyen Nguyen Hoang Mai 2025
Open access · US-GOV
Frailty and 6-Month Clinical Outcomes in Elderly Patients With Heart Failure and Left Ventricular Ejection Fraction >40%
European Journal of Preventive Cardiology 2025
Open access · OA